What (if anything) to do about low-risk prostate cancer
- PMID: 22277569
- DOI: 10.1016/S0140-6736(12)60066-X
What (if anything) to do about low-risk prostate cancer
Comment in
-
Dutasteride and active surveillance of low-risk prostate cancer.Lancet. 2012 Apr 28;379(9826):1590. doi: 10.1016/S0140-6736(12)60678-3. Epub 2012 Apr 26. Lancet. 2012. PMID: 22541581 No abstract available.
Comment on
-
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.Lancet. 2012 Mar 24;379(9821):1103-11. doi: 10.1016/S0140-6736(11)61619-X. Epub 2012 Jan 24. Lancet. 2012. PMID: 22277570 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
